TALEN mediated targeted editing of GM2/GD2-synthase gene modulates anchorage independent growth by reducing anoikis resistance in mouse tumor cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TALEN mediated targeted editing of GM2/GD2-synthase gene modulates anchorage independent growth by reducing anoikis resistance in mouse tumor cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-03-12
DOI
10.1038/srep09048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aiolos Promotes Anchorage Independence by Silencing p66Shc Transcription in Cancer Cells
- (2014) Xichuan Li et al. CANCER CELL
- Making designer mutants in model organisms
- (2014) Y. Peng et al. DEVELOPMENT
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
- (2014) Claudio Mussolino et al. NUCLEIC ACIDS RESEARCH
- microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
- (2014) Aditya Parikh et al. Nature Communications
- Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair
- (2013) T. O. Auer et al. GENOME RESEARCH
- A library of TAL effector nucleases spanning the human genome
- (2013) Yongsub Kim et al. NATURE BIOTECHNOLOGY
- Knockout mice created by TALEN-mediated gene targeting
- (2013) Young Hoon Sung et al. NATURE BIOTECHNOLOGY
- Targeting Human MicroRNA Genes Using Engineered Tal-Effector Nucleases (TALENs)
- (2013) Ruozhen Hu et al. PLoS One
- Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases
- (2013) Li Xu et al. Molecular Therapy-Nucleic Acids
- In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration
- (2012) Sandra Cristea et al. BIOTECHNOLOGY AND BIOENGINEERING
- A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models
- (2012) Qiurong Ding et al. Cell Stem Cell
- Obligate Ligation-Gated Recombination (ObLiGaRe): Custom-designed nuclease-mediated targeted integration through nonhomologous end joining
- (2012) M. Maresca et al. GENOME RESEARCH
- FLASH assembly of TALENs for high-throughput genome editing
- (2012) Deepak Reyon et al. NATURE BIOTECHNOLOGY
- CD4 and CD8 T cells require different membrane gangliosides for activation
- (2012) M. Nagafuku et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice
- (2011) Kimie Niimi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
- (2011) James Finke et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Move over ZFNs
- (2011) NATURE BIOTECHNOLOGY
- Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth
- (2010) Y Liu et al. ONCOGENE
- Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy
- (2010) Sajni Josson et al. PROSTATE
- Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer
- (2010) Thomas N. Seyfried et al. Journal of Oncology
- GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells
- (2009) G. Sa et al. CANCER RESEARCH
- GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells
- (2009) A. Prinetti et al. GLYCOBIOLOGY
- Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction
- (2009) S. Biswas et al. JOURNAL OF IMMUNOLOGY
- STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells
- (2008) P. A. Cohen et al. BLOOD
- GM1 and Tumor Necrosis Factor- , Overexpressed in Renal Cell Carcinoma, Synergize to Induce T-Cell Apoptosis
- (2008) T. Das et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started